Homescientific articlesHair Transplant Risks and Complications: A Mini-Systematic Review and Meta-Analysis Round-Up (2023–2025)
Published on: 24/11/2025
Updated on: 08/09/2026
1 Min
Hair Transplant Risks and Complications: A Mini-Systematic Review and Meta-Analysis Round-Up (2023–2025)
Edited by Dr. Skerdi Faria, with the contribution of the Scientific Committee of the KEIT Day Hospital.
This 2023–2025 review compiles the most recent PubMed-indexed systematic reviews and meta-analyses examining complications in modern hair transplant surgery (FUE, FUT and hybrid techniques). The selected studies analyse donor and recipient-site morbidity, infection, shock loss, graft survival and long-term aesthetic outcomes. Together, they provide an updated, evidence-based picture of complication patterns and risk factors in contemporary hair-restoration surgery.
Table of Contents:
How the evidence was selected: Criteria for the latest five reviews
A targeted PubMed search identified the five most recent systematic reviews and meta-analyses published from 2023 to 2025 that reported post-operative complications or long-term graft survival outcomes. Only high-level evidence was included. The studies assessed donor-site morbidity, recipient-site inflammation, infection, folliculitis, shock loss, technique-dependent risks, graft survival in scarring and non-scarring alopecia and technical variables such as punch diameter, extraction density and implantation strategy. These reviews represent the most comprehensive, up-to-date synthesis of hair transplant safety.
Complications most frequently reported in recent meta-analyses
Hair transplant procedures show a predictable pattern of mild, transient postoperative events. Donor-site discomfort, brief numbness and localized edema are common early reactions. Recipient-site changes, such as crusting and sterile folliculitis appear frequently but rarely lead to long-term problems. Infection, although consistently low, may reach up to 11% but is usually superficial and responsive to standard antibiotics. Shock loss occurs in both donor and recipient regions, while major complications such as necrosis or arteriovenous fistula remain rare.
Typical incidence ranges reported across reviews:
– Donor-site morbidity: 1–15%
– Infection: up to 11%
– Folliculitis: up to ~50%
– Crusting / edema: up to 50%
– Shock loss: 4–6%
– Major complications: rare
Donor-site complications: Pain, numbness and scarring
Donor-site morbidity is among the most frequently reported complications. Early pain, mild swelling and temporary numbness are common but usually resolve quickly, while persistent sensory change occurs in up to 11% of cases. FUT carries a modest risk of hypertrophic or keloid scarring in scar-prone patients, whereas FUE can cause visible thinning if extraction density is excessive. Poor punch control may result in enlarged punctate scars or, rarely, vascular injury. A 2025 meta-analysis also reported isolated donor-site arteriovenous fistulas linked to overly deep punch extraction, underscoring the importance of precise, evenly distributed harvesting.
Key donor-site considerations include:
– Sensory changes: temporary numbness is common; persistent numbness documented in ≤11%.
– Scarring patterns: FUT may form hypertrophic/keloid scars; FUE may create visible thinning if extraction exceeds safe density.
– Punch-related trauma: excessive punch depth/diameter increases the risk of enlarged scars or vascular injury.
– Healing quality: influenced by scalp thickness, vascularity, smoking status and past scarring.
Recipient-site complications: Infection, folliculitis and shock loss
Recipient-site complications consist primarily of early inflammatory responses. Crusting is expected, but if prolonged or inadequately washed it may progress to sterile folliculitis, which appears frequently across recent reviews. Infection remains relatively uncommon, reported up to 11% and typically superficial. Shock loss, involving temporary shedding of native hair, can affect both donor and recipient regions but usually resolves within a few months. Forehead and eyelid edema is another predictable reaction that peaks during the first postoperative days and subsides rapidly.
Long-term graft survival and aesthetic stability
Long-term results vary depending on the underlying alopecia. In androgenetic alopecia, graft survival is usually stable and supported by ongoing medical therapy. In cicatricial alopecia, outcomes differ significantly; a 2025 systematic review documented a decline from over 80% graft survival at one year to around 40% at five years. Aesthetic dissatisfaction often reflects technical factors such as insufficient density, incorrect angulation, uneven growth or donor overharvesting, emphasizing the importance of conservative planning and meticulous technique.
Technique, surgeon factors and patient-related predictors
– FUT provides strong graft survival but carries the burden of a linear scar, particularly when closure tension is high.
– FUE avoids a linear scar but requires controlled punch depth and diameter; uneven or excessive extraction raises the risk of thinning and visible punctate scarring.
– High-density implantation, long operative times and megasessions increase the likelihood of edema, crusting and temporary graft stress.
– Patient factors: smoking, diabetes, vascular insufficiency, low donor density or prior scarring, significantly heighten complication risk.
– Across all reviews, conservative donor harvesting, precise graft handling and rigorous postoperative care consistently reduce adverse outcomes.
Overall hair-transplant risk profile: What this means for practice
– Hair transplant surgery is typically safe, with most complications mild, predictable and short-lived.
– Major complications, including necrosis and arteriovenous fistula, are rare and typically linked to technical errors or high-risk anatomy.
– Long-term success is highest in stable, non-scarring alopecia when donor reserves are preserved and medical therapy continues alongside surgery.
– Clear communication regarding shock loss, donor limitations, density expectations and long-term maintenance is essential for maintaining patient satisfaction.
Bibliography: The five latest PubMed-indexed articles considered
"To offer patients an approach based on excellence, safety, and innovation in the field of aesthetic surgery, with high-level protocols and natural, harmonious results."
Education and Specializations:
• Degree in Medicine and Surgery (1995)
• Specialization in Public Health (2002, with honors, La Sapienza University, Rome)
• Specialization in Anesthesia and Resuscitation (2009, with honors, Tor Vergata University, Rome)
• PhD in Hospital Infections (2005, with honors, La Sapienza University, Rome)
Career and Recognition:
• Founder and Director of KEIT Day Hospital (since 2011)
• Author of numerous scientific studies published on PubMed and Google Scholar
• Expert in aesthetic surgery, hospital infections, and advanced anesthesia protocols
• Gold Medal (1989, Ministry of Public Education – Albania), Energie per Roma (2025, European Center for Cultural Studies – Rome) and others.
Media and Public Recognition:
Dr. Skerdi Faria has been recognized as one of the most influential doctors in the field of aesthetic surgery and has been interviewed and cited by major media outlets in Albania and Italy, including:
• Italy: Rai 1, Rai 2, Rai 3, Mediaset, La7, Corriere della Sera, Il Sole 24 Ore, Il Messaggero, La Gazzetta del Mezzogiorno, Il Tempo, Adnkronos.
• Albania: Top Channel, Klan TV, Vizion Plus, Shqiptarja.com, Panorama, Gazeta Express.